lidocaine hci and epinephrine
Generic: lidocaine hci and epinephrine
Labeler: hf acquisition co llc, dba healthfirstDrug Facts
Product Profile
Brand Name
lidocaine hci and epinephrine
Generic Name
lidocaine hci and epinephrine
Labeler
hf acquisition co llc, dba healthfirst
Dosage Form
INJECTION, SOLUTION
Routes
Active Ingredients
epinephrine bitartrate .01 mg/mL, lidocaine hydrochloride anhydrous 20 mg/mL
Manufacturer
Identifiers & Regulatory
Product NDC
51662-1505
Product ID
51662-1505_12048ce4-ce14-44c3-e063-6394a90ace48
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
NDA
Application Number
NDA006488
Listing Expiration
2026-12-31
Marketing Start
2020-03-11
Pharmacologic Class
Classes
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
516621505
Hyphenated Format
51662-1505
Supplemental Identifiers
RxCUI
UPC
UNII
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
lidocaine hci and epinephrine (source: ndc)
Generic Name
lidocaine hci and epinephrine (source: ndc)
Application Number
NDA006488 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- .01 mg/mL
- 20 mg/mL
Packaging
- 50 mL in 1 VIAL, MULTI-DOSE (51662-1505-1)
- 25 POUCH in 1 CASE (51662-1505-3) / 1 VIAL, MULTI-DOSE in 1 POUCH (51662-1505-2) / 50 mL in 1 VIAL, MULTI-DOSE
Packages (2)
Ingredients (2)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["INFILTRATION", "PERINEURAL"], "spl_id": "12048ce4-ce14-44c3-e063-6394a90ace48", "openfda": {"upc": ["0363323483012"], "unii": ["30Q7KI53AK", "EC2CNF7XFP"], "rxcui": ["1010759"], "spl_set_id": ["a0997348-6274-060a-e053-2a95a90abea7"], "manufacturer_name": ["HF Acquisition Co LLC, DBA HealthFirst"]}, "finished": true, "packaging": [{"sample": false, "description": "50 mL in 1 VIAL, MULTI-DOSE (51662-1505-1)", "package_ndc": "51662-1505-1", "marketing_start_date": "20200311"}, {"sample": false, "description": "25 POUCH in 1 CASE (51662-1505-3) / 1 VIAL, MULTI-DOSE in 1 POUCH (51662-1505-2) / 50 mL in 1 VIAL, MULTI-DOSE", "package_ndc": "51662-1505-3", "marketing_start_date": "20220317"}], "brand_name": "LIDOCAINE HCI AND EPINEPHRINE", "product_id": "51662-1505_12048ce4-ce14-44c3-e063-6394a90ace48", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Adrenergic alpha-Agonists [MoA]", "Adrenergic beta-Agonists [MoA]", "Amide Local Anesthetic [EPC]", "Amides [CS]", "Antiarrhythmic [EPC]", "Catecholamine [EPC]", "Catecholamines [CS]", "Local Anesthesia [PE]", "alpha-Adrenergic Agonist [EPC]", "beta-Adrenergic Agonist [EPC]"], "product_ndc": "51662-1505", "generic_name": "LIDOCAINE HCI AND EPINEPHRINE", "labeler_name": "HF Acquisition Co LLC, DBA HealthFirst", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "LIDOCAINE HCI AND EPINEPHRINE", "active_ingredients": [{"name": "EPINEPHRINE BITARTRATE", "strength": ".01 mg/mL"}, {"name": "LIDOCAINE HYDROCHLORIDE ANHYDROUS", "strength": "20 mg/mL"}], "application_number": "NDA006488", "marketing_category": "NDA", "marketing_start_date": "20200311", "listing_expiration_date": "20261231"}